Commutability is a property of a reference material such that values measured for that reference material and for representative clinical samples have the same relationship between 2, or more, measurement procedures for the same measurand (1, 2 ) . Commutability is required when a reference material will be used as a common calibrator for clinical laboratory measurement procedures or will be used in an external quality assessment (proficiency testing) program to evaluate the agreement among measurement procedures for results from patient samples (3 ) . Commutability is also required when a reference material will be used by an in vitro diagnostics manufacturer as part of their internal traceability procedures to value assign their product calibrators.
In this issue of Clinical Chemistry, Zegers et al. (4 ) report the investigation and validation of commutability for a new reference material for ceruloplasmin, ERM-DA472/IFCC, which was prepared to replace ERM-DA470. The earlier reference material was a serum-based reference material for 15 proteins including ceruloplasmin that had not been validated for commutability but had been reported to improve the agreement among routine clinical laboratory measurement procedures for several proteins (5 ). However, ERM-DA470 did not lead to harmonization of patient sample results for ceruloplasmin, owing to its lack of commutability. The lack of agreement among results from routine procedures was identified by the United Kingdom National External Quality Assessment Scheme program that used commutable samples for performance assessment. The report by Zegers et al. emphasizes both the importance of validating the commutability of a reference material intended to be used as a common calibrator for routine measurement procedures and the responsibility that the reference material provider bears to evaluate commutability as part of the validation of a reference material.
The laboratory medicine profession has recognized the importance of commutability of reference materials that are intended to be used as calibrators in a traceability chain (1, 2 ) . The International Organization for Standardization (ISO) standard 17511:2003 (6 ) addresses metrological traceability of values assigned to calibrators and control materials and states that calibrators are to be commutable at each step in a traceability chain. It is obvious that the purpose of calibration traceability to a higher-order reference material or reference measurement procedure is to provide equivalent results for patient samples when measured using different routine clinical laboratory measurement procedures that purport to measure the same measurand. Unfortunately, the ISO standard is vague regarding traceability requirements of the final results for patient samples. Consequently, situations have been described in which the product calibrators of routine measurement procedures were traceable to a noncommutable reference material, causing lack of agreement for patient samples among the different routine procedures (4, (7) (8) (9) (10) (11) (12) (13) . The ISO standard 17511:2003 is currently being revised and we encourage the working group to carefully address the traceability requirements necessary to ensure that results for patient samples are comparable among different routine measurement procedures.
All providers of reference materials intended to be used either as common calibrators or to assess the agreement of results in external quality assessment/ proficiency-testing programs must take responsibility to ensure that the materials are commutable with representative clinical patient samples. From a practical perspective, it is not possible to evaluate commutability for every measurement procedure in use throughout the world. A reasonable approach would be to evaluate commutability for the commonly used procedures and technologies for a given measurand. A recent CLSI guideline on characterization and qualification of commutable reference materials is available to assist reference material producers with appropriate validation of such materials (14 ) . The developer of less commonly used measurement procedures, including laboratory-developed tests and new procedures introduced to the market, would be responsible for determining if a given reference material is suitable for use with that procedure. Suitable protocols specifically oriented for such assessment need to be developed by the clinical laboratory community.
Commutable reference materials can be challenging to produce because the molecular form of a given analyte may not be well understood or may vary in different clinical conditions for which a biomarker is used to provide diagnostic or therapeutic information. In addition, it may be difficult to obtain adequate quantities of biologic materials that contain appropriate molecular forms of the measurand from which to prepare a reference material. Also contributing to the challenge are factors such as modification of molecular forms during processing of clinical samples, purification of biomarkers of interest, and alteration of the usual sample matrix when preparing materials or adding stabilizing agents. Having a pure form of a biomarker may not be adequate to prepare a suitable matrix-based material for use with routine measurement procedures. For example, a recombinant protein may be available but may not have the appropriate posttranslational glycosylation or molecular complex structure to adequately represent the unaltered clinical measurand. Despite the challenges, commutability remains an essential requirement for a reference material intended for use in a calibration traceability process or for evaluating the agreement among measurement procedures in an external quality assessment (proficiency testing) program.
There are several new developments in laboratory medicine that will contribute to improved harmonization of measurement procedures in the years ahead. The WHO recently convened a consultation on Commutability of WHO Biological Reference Preparations for In Vitro Detection of Infectious Markers. The proceedings are expected to be posted on the WHO website in the near future. Although this conference addressed only biomarkers for infectious diseases, the WHO also provides a substantial number of what are referred to as "International Standards" and "Reference Reagents" in other clinical laboratory disciplines. Many routine measurement procedures have calibrations traceable to these WHO reference materials. Historically, the WHO reference materials have not been evaluated for commutability, and some have been reported not to achieve agreement among patient sample results (7) (8) (9) (10) (11) . We applaud the WHO for recognizing the importance of commutability of reference materials to ensure that they are fit for their intended use, and we look forward to commutability evaluation in future and renewed batches of their reference materials.
The Joint Committee for Traceability in Laboratory Medicine lists reference materials, reference measurement procedures, and laboratories performing the reference procedures that have been reviewed for conformance to ISO standards and are intended for use in establishing the calibration traceability of routine clinical laboratory measurement procedures. The Quality Manual of Working Group 1 has added a requirement to include commutability assessment of reference materials to be considered for listing in the database (15 ) .
The IFCC Scientific Division has recently established a working group on commutability. The working group is charged with further developing procedures for the formal assessment of commutability and addressing the criteria for stating a reference material is commutable on the basis of the intended clinical use of a measurand. Issues such as the confounding influences of measurement specificity, evaluation of replacement lots of a reference material, and assessment of commutability of an existing material with a new measurement procedure are among the items to be addressed by this working group.
The AACC has led development of the International Consortium for Harmonization of Clinical Laboratory Results. This new program addresses a need identified at an international forum in 2010 (2 ) to organize global efforts to harmonize test results. The program aims to provide a centralized process for identification and prioritization of measurands in need of harmonization based on their clinical importance and use in clinical practice guidelines. The program will assess technical feasibility to achieve harmonization, provide an information portal on harmonization activities by organizations around the world, and foster cooperation among organizations to avoid duplication of work as well as to promote common harmonization schemes. The consortium has developed a toolbox of approaches to address harmonization of measurands for which there is no reference measurement procedure and for which there may not be a reference material. These tools, including the requirement for commutability assessment of reference materials, will provide a starting point for development of protocols for harmonization of these more difficult measurands. The consortium will also solicit funding and appoint harmonization implementation groups to achieve harmonization for high-priority measurands. Further information is available at the website www.harmonization.net.
We find it encouraging that since our editorial on the importance of commutability in 2006, the clinical laboratory community has taken positive steps to address the problem of inadequate comparability of results for patient samples caused by ignoring this important property of reference materials. It will take some time to address all of the technical challenges associated with providing and validating commutable reference materials. However, effective use of clinical practice guidelines that depend on laboratory test results to make a diagnosis and to guide treatment requires those results to be comparable irrespective of the measurement procedure used, or the location or time the measurements are made. As Zegers et al. have demon-strated, commutability of reference materials is an essential requirement to achieve comparability of patient results.
